These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 16148886)

  • 1. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.
    Brabletz T; Jung A; Spaderna S; Hlubek F; Kirchner T
    Nat Rev Cancer; 2005 Sep; 5(9):744-9. PubMed ID: 16148886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
    Spaderna S; Schmalhofer O; Hlubek F; Jung A; Kirchner T; Brabletz T
    Verh Dtsch Ges Pathol; 2007; 91():21-8. PubMed ID: 18314592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
    Haura EB
    Med Hypotheses; 2006; 67(4):951-6. PubMed ID: 16714090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-microenvironmental interactions: paths to progression and targets for treatment.
    Box C; Rogers SJ; Mendiola M; Eccles SA
    Semin Cancer Biol; 2010 Jun; 20(3):128-38. PubMed ID: 20599506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cell hydration promotes both tumor growth and metastasis: a biochemical mechanism consistent with genetic signatures.
    McIntyre GI
    Med Hypotheses; 2007; 69(5):1127-30. PubMed ID: 17399912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis.
    Koten JW; Neijt JP; Zonnenberg BA; Den Otter W
    Anticancer Res; 1993; 13(4):1179-82. PubMed ID: 8352541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].
    Klein CA
    Verh Dtsch Ges Pathol; 2003; 87():158-64. PubMed ID: 16888908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stem cells in development and cancer.
    Brabletz S; Schmalhofer O; Brabletz T
    J Pathol; 2009 Jan; 217(2):307-17. PubMed ID: 19031475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids.
    Vincan E; Darcy PK; Farrelly CA; Faux MC; Brabletz T; Ramsay RG
    Oncogene; 2007 Apr; 26(16):2340-52. PubMed ID: 17016432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
    Vincan E; Brabletz T; Faux MC; Ramsay RG
    Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The migrating cancer stem cells model--a conceptual explanation of malignant tumour progression.
    Jung A; Brabletz T; Kirchner T
    Ernst Schering Found Symp Proc; 2006; (5):109-24. PubMed ID: 17939298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.
    Mimeault M; Batra SK
    Cancer Metastasis Rev; 2007 Mar; 26(1):203-14. PubMed ID: 17273942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis.
    Soreide K; Janssen EA; Körner H; Baak JP
    J Pathol; 2006 Jun; 209(2):147-56. PubMed ID: 16691544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative model of cancer cell growth and metastasis.
    Vaidya JS
    Int J Surg; 2007 Apr; 5(2):73-5. PubMed ID: 17448967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase in tumour progression: friend or foe?
    Kotsakis P; Griffin M
    Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression.
    Milicevic Z; Bogojevic D; Mihailovic M; Petrovic M; Krivokapic Z
    Int J Oncol; 2008 Jun; 32(6):1169-78. PubMed ID: 18497978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
    Sánchez-García I; Vicente-Dueñas C; Cobaleda C
    Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review).
    Neureiter D; Herold C; Ocker M
    Int J Mol Med; 2006 Mar; 17(3):483-9. PubMed ID: 16465396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.